Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia Failure or Relapse After First-line Treatment

NCT04423367 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Acquired Pure Red Cell Aplasia

Interventions

DRUG: bortezomib/dexamethasone

Sponsor

Institute of Hematology & Blood Diseases Hospital, China